0001384101-24-000045.txt : 20240319 0001384101-24-000045.hdr.sgml : 20240319 20240319165002 ACCESSION NUMBER: 0001384101-24-000045 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240315 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chambers Rebecca CENTRAL INDEX KEY: 0001823563 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36156 FILM NUMBER: 24764214 MAIL ADDRESS: STREET 1: 3052 ORCHARD DR. CITY: SAN JOSE STATE: CA ZIP: 95134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERACYTE, INC. CENTRAL INDEX KEY: 0001384101 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 205455398 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 243-6300 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT, SUITE 300 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: CALDEROME INC DATE OF NAME CHANGE: 20061219 4 1 wk-form4_1710881393.xml FORM 4 X0508 4 2024-03-15 0 0001384101 VERACYTE, INC. VCYT 0001823563 Chambers Rebecca 6000 SHORELINE COURT SUITE 300 SOUTH SAN FRANCISCO CA 94080 0 1 0 0 Chief Financial Officer 0 Common Stock 2024-03-15 4 A 0 4318 0 A 148891 D Common Stock 2024-03-15 4 F 0 2189 21.10 D 146702 D Represents the acquisition of restricted stock units ("RSUs") earned by the Reporting Person upon the achievement of performance goals for the one-year period ended December 31, 2023, as reflected in the financial statements and certified by the Compensation Committee of the Board of Directors on March 15, 2024. The RSUs vested March 15, 2024. The reporting person is reporting the withholding of 2,189 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the vesting of 4,189 Performance Stock Units vested on March 15, 2024 and does not represent a sale by the reporting person. /s/ Jonathan Wygant as attorney-in-fact 2024-03-19